Trial Site Detail
Drug: |
Imatinib |
|||
|---|---|---|---|---|
Trial: |
The Stop-GIST Trial: Discontinuation of Imatinib in Patients With Oligo-metastatic GIST |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Suspended |
|||
Oslo University Hospital |
Principal Investigator: |
Øyvind S Bruland, MD PhD |
|---|---|
Contact: |
22934767 ext 47 osb@ous-hf.no |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Oslo University Hospital Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.